Your Best Stock
Stocks Top Retailers CVS

CVS Health CVS

US equityMarket cap rank #143Top Retailers
$84.66
−$1.21 (-1.40%)
Market open · Sep 24, 1:10 pm ET
After hours $86.10 +0.28%
Open$85.80
Prev close$85.86
Day range$84.50 – $86.01
Volume2.91M
Market cap$108.27B
P/E (TTM)22.3
Dividend yield3.14%

Fundamentals

Latest reported quarter: Q2, ended Jun 2026

Revenue$106.10B+7.3% YoY
Operating profit$4.70B+97.5% YoY
Net profit$3.00B+195.7% YoY
Diluted EPS$2.31+188.8% YoY
Free cash flow$5.65B+338.3% YoY
Operating cash flow$6.35B

Revenue, last 8 quarters

$95.4BSep '24$97.7BDec '24$94.6BMar '25$98.9BJun '25$102.9BSep '25$105.7BDec '25$100.4BMar '26$106.1BJun '26

Net profit, last 8 quarters

$71.0MSep '24$1.6BDec '24$1.8BMar '25$1.0BJun '25$-4.0BSep '25$2.9BDec '25$3.0BMar '26$3.0BJun '26

Diluted EPS by quarter

0.07Sep '241.30Dec '241.41Mar '250.80Jun '25-3.13Sep '252.30Dec '252.30Mar '262.31Jun '26

Free cash flow by quarter

$-1.4BSep '24$1.1BDec '24$3.8BMar '25$1.3BJun '25$98.0MSep '25$2.6BDec '25$3.4BMar '26$5.7BJun '26

Annual revenue

$268.7BFY20$292.1BFY21$322.5BFY22$357.8BFY23$372.8BFY24$402.1BFY25

Profitability & balance sheet

Gross margin14.2%
Operating margin3.4%
Net margin1.2%
Return on equity6.2%
Return on assets1.9%
Return on invested capital4.8%
Current ratio0.87
Liabilities / assets68.5%
Cash & investments$13.96B
Total debt$74.39B
Net cash (debt)-$60.43B
Free cash flow / sales2.8%

Where the revenue comes from

Quarter 2026/Q2

By business line

  • Health services$51.80B 42.0%
  • Health Care Benefits$37.54B 30.4%
  • Pharmacy & Consumer Wellness$33.82B 27.4%
  • Corporate/other$147.00M 0.1%

Income statement

Line item 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4 2025 Q3
Total Revenue as Reported $106.10B $100.43B $402.07B $105.69B $102.87B
Total Operating Revenue $106.10B $100.43B $402.07B $105.69B $102.87B
Cost of Revenue $90.35B $84.80B $346.71B $92.13B $89.07B
Gross Profit $15.75B $15.62B $55.36B $13.57B $13.81B
Operating Expense $11.05B $10.94B $44.98B $11.46B $11.29B
Other Operating Expenses $11.05B $10.94B $44.98B $11.46B $11.29B
Operating Profit $4.70B $4.68B $10.39B $2.11B $2.52B
Net Non-Operating Interest Income (Expense) -$757.00M -$774.00M -$3.12B -$787.00M -$784.00M
Non-Operating Interest Expense $757.00M $774.00M $3.12B $787.00M $784.00M
Other Income (Expense) $31.00M $32.00M -$5.13B $29.00M -$5.22B
Other Non-Operating Income (Expenses) $31.00M $32.00M $112.00M $29.00M $26.00M
Pretax Profit $3.98B $3.94B $2.14B $1.35B -$3.48B
Tax $982.00M $981.00M $408.00M -$1.57B $508.00M
Net Profit $3.00B $2.96B $1.73B $2.92B -$3.99B
Profit from Continuing Operations $3.00B $2.96B $1.73B $2.92B -$3.99B
Minority Interests $16.00M $14.00M -$40.00M -$20.00M -$15.00M
Net Income to Parent Company $2.98B $2.94B $1.77B $2.94B -$3.98B
Net Income to Common Stockholders $2.98B $2.94B $1.77B $2.94B -$3.98B
Basic EPS $2.33 $2.31 $1.40 $2.32 -$3.13
Diluted EPS $2.31 $2.30 $1.39 $2.30 -$3.13
Dividend Per Share $0.67 $0.67 $2.66 $0.67 $0.67
Special Income (Charges) -$5.24B $0.00 -$5.24B
-Less:Restructuring and Mergern & Acquisition $0.00 $0.00 $0.00
-Less:Impairment of Capital Assets $5.73B $0.00 $5.73B
-Gain on Sale Of Business $483.00M $0.00 $483.00M
-Gain on Sale of Property/Plant/Equipment $0.00

Balance sheet

Line item 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4 2025 Q3
Total Assets $253.77B $252.97B $253.54B $253.54B $255.33B
Total Current Assets $75.35B $74.82B $74.71B $74.71B $77.11B
Cash and Cash Equivalents & Short-Term Investments $13.96B $11.80B $10.60B $10.60B $11.23B
-Cash and Cash Equivalents $11.33B $9.54B $8.45B $8.45B $9.10B
-Short Term Investments $2.63B $2.26B $2.15B $2.15B $2.13B
Receivables $40.31B $40.99B $39.78B $39.78B $43.86B
-Accounts Receivable $19.38B $20.14B $16.32B $16.32B $16.10B
-Other Receivables $20.93B $20.85B $23.46B $23.46B $27.76B
Inventory $17.62B $17.77B $19.25B $19.25B $18.96B
Other Current Assets $3.46B $4.25B $5.09B $5.09B $3.06B
Total Non-Current Assets $178.42B $178.16B $178.82B $178.82B $178.22B
Net PPE $27.62B $27.78B $28.06B $28.06B $28.11B
-Gross PPE $27.62B $27.78B $52.80B $52.80B $28.11B
Investments and Advances $33.25B $32.41B $32.67B $32.67B $31.55B
-Available for Sale Securities $26.93B $26.29B $26.72B $26.72B $25.86B
-Held to Maturity Securities $1.32B $1.34B $1.38B $1.38B $1.37B
Goodwill and Other Intangible Assets $110.12B $110.55B $110.99B $110.99B $111.46B
-Goodwill $85.48B $85.48B $85.48B $85.48B $85.48B
-Other Intangible Assets $24.64B $25.07B $25.51B $25.51B $25.98B
Other Non-Current Assets $7.43B $7.42B $5.12B $5.12B $5.16B
Total Liabilities $173.87B $175.34B $178.16B $178.16B $182.22B
Total Current Liabilities $87.04B $86.41B $88.69B $88.69B $92.70B
Payables $59.68B $58.59B $59.38B $59.38B $60.95B
-Accounts Payable $17.17B $16.92B $17.64B $17.64B $17.76B
-Other Payable $42.52B $41.67B $41.74B $41.74B $43.18B
Current Accrued Expenses $22.48B $22.26B $22.39B $22.39B $23.42B
Short-Term Debt and Capital Lease Obligation $3.87B $4.48B $5.81B $5.81B $7.24B
-Current Debt $1.96B $2.58B $4.07B $4.07B $5.33B
-Current Capital Lease Obligation $1.91B $1.90B $1.74B $1.74B $1.91B
Other Current Liabilities $1.01B $1.08B $1.12B $1.12B $1.10B
Total Non-Current Liabilities $86.83B $88.93B $89.46B $89.46B $89.52B
Long Term Debt and Capital Lease Obligation $72.43B $73.86B $74.15B $74.15B $74.52B
-Long Term Debt $59.45B $60.53B $60.50B $60.50B $60.51B
-Long Term Capital Lease Obligation $12.98B $13.33B $13.64B $13.64B $14.01B
Non-Current Deferred Liabilities $3.77B $3.77B $3.83B $3.83B $3.55B
Other Non-Current Liabilities $10.63B $11.30B $9.49B $9.49B $9.53B
Total Equity $79.90B $77.64B $75.38B $75.38B $73.11B
Stockholders' Equity $79.70B $77.46B $75.21B $75.21B $72.93B
Capital Stock $50.97B $50.68B $50.40B $50.40B $50.18B
-Common Stock $50.97B $50.68B $50.40B $50.40B $50.18B
-Preferred Stock $0.00 $0.00 $0.00 $0.00 $0.00
Retained Earnings $65.40B $63.28B $61.20B $61.20B $59.11B
Less: Treasury Stock $36.85B $36.71B $36.79B $36.79B $36.78B
Gains/Losses Not Affecting Retained Earnings $188.00M $201.00M $406.00M $406.00M $416.00M
Minority Interests $197.00M $181.00M $168.00M $168.00M $182.00M
-Accumulated Depreciation -$24.74B -$24.74B
Defined Pension Benefit $1.99B $1.99B $1.93B
Employee Benefits $1.99B $1.99B $1.93B

Cash flow

Line item 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4 2025 Q3
Operating Cash Flow $6.35B $4.25B $10.64B $3.39B $796.00M
Net cash flow from continuing operations $6.35B $4.25B $10.64B $3.39B $796.00M
Net Income from Continuing Operations $3.00B $2.96B $1.73B $2.92B -$3.99B
Depreciation & Depletion & Amortization $1.13B $1.12B $4.61B $1.15B $1.13B
Deferred Tax -$150.00M -$91.00M $102.00M $542.00M -$157.00M
Change in Working Capital $2.20B $2.00M -$1.47B -$1.02B -$1.57B
-Change in Receivables $672.00M -$1.21B -$3.50B $4.04B -$3.40B
-Change in Inventory $148.00M $1.48B -$1.27B -$285.00M -$1.65B
-Change in Payables and Accrued Expense $873.00M -$552.00M $3.87B -$1.92B $1.99B
-Change in Other Current Assets $876.00M $479.00M -$2.59B -$2.01B $381.00M
-Change in Other Current Liabilities -$371.00M -$196.00M $2.01B -$855.00M $1.11B
Net cash flow from investing -$1.88B -$874.00M -$5.87B -$2.00B -$2.09B
Net Cash Flow from Continuing Investing Activities -$1.88B -$874.00M -$5.87B -$2.00B -$2.09B
Net PPE Purchase and Sale -$691.00M -$849.00M -$2.83B -$784.00M -$698.00M
Net Business Purchase and Sale -$4.00M -$5.00M -$436.00M -$7.00M -$290.00M
Net Investment Purchase and Sale -$1.19B -$27.00M -$2.63B -$1.22B -$1.09B
Net Other Investing Changes $5.00M $7.00M $26.00M $17.00M -$14.00M
Financing Cash Flow -$2.69B -$2.32B -$4.94B -$2.03B -$1.38B
Net Cash Flow from Continuing Financing Activities -$2.69B -$2.32B -$4.94B -$2.03B -$1.38B
Net Issuance Payments Of Debt -$1.77B -$1.52B -$1.78B -$1.27B -$671.00M
Cash Dividends Paid -$878.00M -$847.00M -$3.40B -$845.00M -$846.00M
Proceeds from Stock Option Exercised $114.00M $103.00M $394.00M $86.00M $117.00M
Net Other Financing Charges -$160.00M -$56.00M -$158.00M -$6.00M $18.00M
Ending Cash Balance $11.54B $9.77B $8.71B $8.71B $9.35B
Net Change in Cash $1.77B $1.06B -$172.00M -$640.00M -$2.67B
Beginning Cash Balance $9.77B $8.71B $8.88B $9.35B $12.03B
Free Cash Flow $5.65B $3.40B $7.81B $2.61B $98.00M
Gain/Loss from Continuing Operations -$247.00M $0.00 -$483.00M
Other Non-Cash Items -$336.00M
Net Common Stock Issuance $0.00 $0.00 $0.00
Scroll to Top